Cell Viability Assays Market by Product (Consumables and Instruments), by Application (Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, and Others), and by End-User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Others)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029

                                          
Abstract
                    
The report covers a forecast and an analysis of the cell viability assays market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the cell viability assays market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the cell viability assays market on a global level.

In order to give the users of this report a comprehensive view of the cell viability assays market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new assay kits launch, agreements, partnerships, collaborations & joint ventures, research & development,  and regional expansion of major participants involved in the market.

The study provides a decisive view of the cell viability assays market on the basis of product, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some key players of the global cell viability assays market are Bio-Rad Laboratories, Inc., GE Healthcare, PerkinElmer, Danaher Corporation, Promega Corporation, Thermo Fischer Scientific, BioTek Instruments, Biotium, Merck, Becton, Dickinson, and Company, and G-Biosciences, among others.

This report segments the global cell viability assays market as follows:

Global Cell Viability Assays Market: Product Analysis

	Consumables
	
		Assay Kits
		
			Tetrazolium Reduction Assay Kits
			Resazurin Cell Viability Assay Kits
			Calcein-AM Cell Viability Assay Kits
			Others
		
		
		Reagents
		Microplates
	
	
	Instruments
	
		Automated Cell Counters
		Spectrophotometers
		Cell Imaging and Analysis Systems
		Flow Cytometers
	
	

Global Cell Viability Assays Market: Application Analysis

	Basic Research
	Stem Cell Research
	Drug Discovery and Development
	Clinical and Diagnostic Applications
	Others

Global Cell Viability Assays Market: End-User Analysis

	Academic and Research Institutes
	Pharmaceutical and Biotechnology Companies
	Hospitals and Diagnostic Laboratories
	Others

Global Cell Viability Assays Market: Regional Analysis

	North America
	
		U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa